Cisplatin: The first metal based anticancer drug

S Ghosh - Bioorganic chemistry, 2019 - Elsevier
Abstract Cisplatin or (SP-4-2)-diamminedichloridoplatinum (II) is one of the most potential
and widely used drugs for the treatment of various solid cancers such as testicular, ovarian …

Cisplatin in cancer therapy: molecular mechanisms of action

S Dasari, PB Tchounwou - European journal of pharmacology, 2014 - Elsevier
Cisplatin, cisplatinum, or cis-diamminedichloroplatinum (II), is a well-known
chemotherapeutic drug. It has been used for treatment of numerous human cancers …

Melittin, a major peptide component of bee venom, and its conjugates in cancer therapy

I Rady, IA Siddiqui, M Rady, H Mukhtar - Cancer letters, 2017 - Elsevier
Melittin (MEL), a major peptide component of bee venom, is an attractive candidate for
cancer therapy. This agent has shown a variety of anti-cancer effects in preclinical cell …

Applications and evolution of melittin, the quintessential membrane active peptide

S Guha, RP Ferrie, J Ghimire, CR Ventura, E Wu… - Biochemical …, 2021 - Elsevier
Melittin, the main venom component of the European Honeybee, is a cationic linear peptide-
amide of 26 amino acid residues with the sequence: GIGAVLKVLTTGLPALISWIKRKRQQ …

Antimicrobial Properties of Apis mellifera's Bee Venom

H El-Seedi, A Abd El-Wahed, N Yosri, SG Musharraf… - Toxins, 2020 - mdpi.com
Bee venom (BV) is a rich source of secondary metabolites from honeybees (Apis mellifera
L.). It contains a variety of bioactive ingredients including peptides, proteins, enzymes, and …

Chemical characterization, antioxidant, anti-inflammatory and cytotoxic properties of bee venom collected in Northeast Portugal

F Sobral, A Sampaio, S Falcão, MJRP Queiroz… - Food and Chemical …, 2016 - Elsevier
Bee venom (BV) or apitoxin is a complex mixture of substances with reported biological
activity. In the present work, five bee venom samples obtained from Apis mellifera iberiensis …

Application of bee venom and its main constituent melittin for cancer treatment

C Liu, D Hao, Q Zhang, J An, J Zhao, B Chen… - Cancer chemotherapy …, 2016 - Springer
Bee venom and its main constituent melittin (MEL) have been extensively studied in the
treatment of tumors. However, the non-specific cytotoxicity and hemolytic activity have …

Synergistic effects of melittin and plasma treatment: A promising approach for cancer therapy

P Shaw, N Kumar, D Hammerschmid… - Cancers, 2019 - mdpi.com
Melittin (MEL), a small peptide component of bee venom, has been reported to exhibit anti-
cancer effects in vitro and in vivo. However, its clinical applicability is disputed because of its …

Low doses of cisplatin induce gene alterations, cell cycle arrest, and apoptosis in human promyelocytic leukemia cells

V Velma, SR Dasari, PB Tchounwou - Biomarker insights, 2016 - journals.sagepub.com
Cisplatin is a known antitumor drug, but its mechanisms of action are not fully elucidated. In
this research, we studied the anticancer potential of cisplatin at doses of 1, 2, or 3 μM using …

Anticancer activity of toxins from bee and snake venom—An overview on ovarian cancer

MA Moga, OG Dimienescu, CA Arvătescu, P Ifteni… - Molecules, 2018 - mdpi.com
Cancer represents the disease of the millennium, a major problem in public health. The
proliferation of tumor cells, angiogenesis, and the relationship between the cancer cells and …